Summit Global Investments Repligen Corp Transaction History

Summit Global Investments

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$247.59 - $304.47 $742,770 - $913,410	-3,000 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$194.77 - $324.21 $1.62 Million - $2.7 Million	-8,320 Reduced 73.5%	3,000 $867,000
Q2 2021 Jan 28, 2022	BUY	$165.87 - $220.95 $106,322 - $141,628	641 Added 6.0%	11,320 $2.26 Million
Q1 2021 Jan 27, 2022	SELL	$180.37 - $226.26 $557,884 - $699,822	-3,093 Reduced 22.46%	10,679 $2.08 Million
Q4 2020 Feb 11, 2021	SELL	$148.08 - $206.57 $173,845 - $242,513	-1,174 Reduced 7.85%	13,772 $2.64 Million
Q3 2020 Nov 16, 2020	BUY	$122.51 - $158.27 $1.48 Million - $1.91 Million	12,046 Added 415.38%	14,946 $2.21 Million
Q2 2020 Aug 11, 2020	BUY	$94.33 - $140.48 $273,557 - $407,391	2,900 New	2,900 $358,000

485

54.1M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $9.21B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Summit Global Investments, based on Form 13F filings with the SEC.

Stay updated on Summit Global Investments with notifications on news.